Inventor · disambiguated record
Kaneyoshi Kato
Also filed as: KATO KANEYOSHI · TERAO SHINJI · YAMAMOTO MITSUO
23 granted patents·3 pending applications·660 citations·filing 1977–2005
97Inventor score
Files withTAKEDA CHEMICAL INDUSTRIES LTD19TAKEDA PHARMACEUTICAL2IHARA CHEMICAL IND CO1KATO KANEYOSHI1SENJU PHARMACEUTICALS CO LTD1
Top patents by PatentIndex Score
26 records- 0195US7115750B1Melanin concentrating hormone antagonistTAKEDA PHARMACEUTICAL·Filed 2000·Granted Oct 3, 2006·45 cites·14 claims
- 0295US4388312AQuinone derivatives, their production and useTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1980·Granted Jun 14, 1983·58 cites·8 claims
- 0393US6310107B1Amine compounds, their production and use as amyloid-β production inhibitorsTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1998·Granted Oct 30, 2001·48 cites·7 claims
- 0493US4199531AIntermediates for the production of quinonesTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1977·Granted Apr 22, 1980·29 cites·14 claims
- 0592US5804601AAromatic hydroxamic acid compounds, their production and useTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1996·Granted Sep 8, 1998·79 cites·16 claims
- 0691US6613805B2Amine compounds, their production and useTAKEDA CHEMICAL INDUSTRIES LTD·Filed 2001·Granted Sep 2, 2003·24 cites·33 claims
- 0790US5654296ACondensed heterocyclic compounds, their production and useTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1996·Granted Aug 5, 1997·52 cites·24 claims
- 0889US6329389B1Amine compounds, their production and useTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1999·Granted Dec 11, 2001·50 cites·28 claims
- 0988US6586475B1β-amyloid protein production/secretion inhibitorsTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1999·Granted Jul 1, 2003·39 cites·26 claims
- 1086US4533554AQuinone derivatives and useTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1983·Granted Aug 6, 1985·20 cites·12 claims
- 1185US6930104B2Heterocyclic derivativesTAKEDA CHEMICAL INDUSTRIES LTD·Filed 2002·Granted Aug 16, 2005·27 cites·20 claims
- 1285US6784314B2Process for producing amine derivativesTAKEDA CHEMICAL INDUSTRIES LTD·Filed 2001·Granted Aug 31, 2004·23 cites·10 claims
- 1382US4939128AEster of ascorbic acid 2-phosphate and pharmaceutical useTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1989·Granted Jul 3, 1990·30 cites·12 claims
- 1479US5633248AAmine compounds, their production and useTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1995·Granted May 27, 1997·24 cites·18 claims
- 1577US5466689AMorpholine derivatives and their useTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1994·Granted Nov 14, 1995·17 cites·11 claims
- 1675US5591849ASpiro[naphthalene-2(1H),2'-piperidine] and their useTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1995·Granted Jan 7, 1997·20 cites·10 claims
- 1770US5607939ACondensed heterocyclic compounds, their production and useTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1995·Granted Mar 4, 1997·13 cites·23 claims
- 1866US5410009APolyurethaneurea elastomerIHARA CHEMICAL IND CO·Filed 1993·Granted Apr 25, 1995·14 cites·7 claims
- 1963US5891916AAromatic hydroxamix acid compounds, their production and useTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1996·Granted Apr 6, 1999·9 cites·12 claims
- 2061US5272180ACell proliferation inhibitorTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1992·Granted Dec 21, 1993·26 cites·3 claims
- 2160US7256204B2Amine compounds, their production and useTAKEDA PHARMACEUTICAL·Filed 2003·Granted Aug 14, 2007·1 cites·22 claims
- 2254US2007173498A1Melanin concentrating hormone antagonistKATO KANEYOSHI·Filed 2005·Application pending·0 cites
- 2346US2001003751A1Pharmaceutical composition for treating transient ischemic attackFiled 2001·Application pending·0 cites
- 2445US2003216398A1Soluble beta amyloid precursor protein secretion promotersFiled 2001·Application pending·0 cites
- 2541US5665769APharmaceutical composition for preventing and treating retinal diseasesSENJU PHARMACEUTICALS CO LTD·Filed 1994·Granted Sep 9, 1997·10 cites·11 claims
- 2640US6326369B1Bicyclic quinone compounds, their production and useTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1998·Granted Dec 4, 2001·2 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Kaneyoshi Kato files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →